Disrupting Alzheimer's

We are living in a new era of medicine, where treatments and even cures once believed to be impossible are today a reality. But this immense progress does not apply universally and there have been...
Read More
A new era in Alzheimer’s innovation

After heart disease and cancer, Alzheimer’s disease and dementia are the leading cause of death for seniors, responsible for one out of every three deaths. Today, the disease devastates the minds of...
Read More
New report shows over 500 medicines in development for neurological disorders

Neurological disorders, which include more than 1,000 conditions that disrupt the brain and nervous system, affect an estimated 100 million Americans, nearly one third of the U.S. population....
Read More
ICYMI – Report highlights increasing prevalence for Alzheimer’s disease

The number of Americans affected by Alzheimer’s disease (AD) continues to rise according to a new report.1 Researchers found that approximately 6.08 million Americans had Alzheimer’s or mild...
Read More
Profiles in courage: Latinos in the fight against Alzheimer’s

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday: How finding an Alzheimer’s treatment could lower Medicare spending

Alzheimer’s disease is devastating and impacts more than 5.5 million Americans and their families. While America’s biopharmaceutical researchers have been working tirelessly to find a cure for the...
Read More
Continuing the search for new Alzheimer’s therapies

Designated in 1983 by then-President Ronald Reagan, November marks National Alzheimer’s Disease Awareness Month – a month for all Americans to come together to raise awareness and understanding of...
Read More
Dr. George Scangos: Not just science for science’s sake

America’s biopharmaceutical researchers are working tirelessly to develop new and innovative medicines for patients. For those diseases that have no treatment options, the opportunity to improve...
Read More
Using setbacks as stepping stones in Alzheimer’s research

For decades, biopharmaceutical researchers have worked tirelessly in the pursuit of new treatments and cures for the costly and devastating Alzheimer’s disease. Advancing treatments for Alzheimer’s...
Read More
Biopharmaceutical industry is essential to development of Alzheimer’s treatments

This week, presidential candidate Hillary Clinton called for a spending increase by the federal government to find a cure to the costly and devastating Alzheimer’s disease. Finding a better treatment...
Read More